Form 4 for BIO BIO-RAD LABORATORIES, INC.
Accepted 2024-09-04 00:00:00 ET · period of report 2024-09-01 · accession 0001062993-24-016174 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-09-04 | 2024-09-01+ | BIO | SCHWARTZ NORMAN D | COB, Pres, CEO, Dir, 10% | M - OptEx | $0.00 | +10.5K | 439.5K | +2% | $0 |
| DM | 2024-09-04 | 2024-09-01+ | BIO | SCHWARTZ NORMAN D | COB, Pres, CEO, Dir, 10% | F - Tax | $336.60 | -5,159 | 434.3K | -1% | -$1.74M |
| DM | 2024-09-04 | 2024-09-01+ | BIO | SCHWARTZ NORMAN D | COB, Pres, CEO, Dir, 10% | M - OptEx | $0.00 | -10.5K | 1,266 | -89% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Bio-Rad A Common Stock | 2024-09-01 | M | A | 1,266 | $0.00 | 436,864 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 2 | Common | Bio-Rad A Common Stock | 2024-09-01 | F | D | 545 | $337.32 | 436,319 | D | — | — | |
| 3 | Common | Bio-Rad A Common Stock | 2024-09-02 | M | A | 1,805 | $0.00 | 438,124 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 4 | Common | Bio-Rad A Common Stock | 2024-09-02 | F | D | 965 | $337.32 | 437,159 | D | — | — | |
| 5 | Common | Bio-Rad A Common Stock | 2024-09-01 | F | D | 801 | $337.32 | 435,598 | D | — | — | |
| 6 | Common | Bio-Rad A Common Stock | 2024-09-03 | F | D | 1,241 | $334.31 | 438,238 | D | — | — | |
| 7 | Common | Bio-Rad A Common Stock | 2024-09-01 | M | A | 3,005 | $0.00 | 435,925 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 8 | Common | Bio-Rad A Common Stock | 2024-09-01 | F | D | 1,607 | $337.32 | 434,318 | D | — | — | |
| 9 | Common | Bio-Rad A Common Stock | 2024-09-01 | M | A | 2,081 | $0.00 | 436,399 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 10 | Common | Bio-Rad A Common Stock | 2024-09-03 | M | A | 2,320 | $0.00 | 439,479 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 11 | Derivative | Restricted Stock Units | 2024-09-01 | M | D | 3,005 | $0.00 | 9,015 | D | $0.00 · — to — | 3,005 Bio-Rad A Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F5) On September 1, 2023, the reporting person was granted 12,020 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 12 | Derivative | Restricted Stock Units | 2024-09-01 | M | D | 2,081 | $0.00 | 4,164 | D | $0.00 · — to — | 2,081 Bio-Rad A Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F6) On September 1, 2022, the reporting person was granted 8,326 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 13 | Derivative | Restricted Stock Units | 2024-09-03 | M | D | 2,320 | $0.00 | 0 | D | $0.00 · — to — | 2,320 Bio-Rad A Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F9) On September 3, 2019, the reporting person was granted 11,597 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |
| 14 | Derivative | Restricted Stock Units | 2024-09-02 | M | D | 1,805 | $0.00 | 0 | D | $0.00 · — to — | 1,805 Bio-Rad A Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F8) On September 2, 2020, the reporting person was granted 7,220 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 15 | Derivative | Restricted Stock Units | 2024-09-01 | M | D | 1,266 | $0.00 | 1,266 | D | $0.00 · — to — | 1,266 Bio-Rad A Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F7) On September 1, 2021, the reporting person was granted 5,064 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |